622 related articles for article (PubMed ID: 2910757)
1. Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.
Levine DS; Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
Gastroenterology; 1989 Feb; 96(2 Pt 1):355-67. PubMed ID: 2910757
[TBL] [Abstract][Full Text] [Related]
2. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study.
Levine DS; Rubin CE; Reid BJ; Haggitt RC
Lab Invest; 1989 Mar; 60(3):418-32. PubMed ID: 2927081
[TBL] [Abstract][Full Text] [Related]
3. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.
Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
Gastroenterology; 1987 Jul; 93(1):1-11. PubMed ID: 3582897
[TBL] [Abstract][Full Text] [Related]
4. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.
Reid BJ; Blount PL; Rubin CE; Levine DS; Haggitt RC; Rabinovitch PS
Gastroenterology; 1992 Apr; 102(4 Pt 1):1212-9. PubMed ID: 1551528
[TBL] [Abstract][Full Text] [Related]
5. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus.
Fennerty MB; Sampliner RE; Way D; Riddell R; Steinbronn K; Garewal HS
Gastroenterology; 1989 Oct; 97(4):815-20. PubMed ID: 2777038
[TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus, dysplasia, and adenocarcinoma.
Haggitt RC
Hum Pathol; 1994 Oct; 25(10):982-93. PubMed ID: 7927321
[TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk.
Haggitt RC; Reid BJ; Rabinovitch PS; Rubin CE
Am J Pathol; 1988 Apr; 131(1):53-61. PubMed ID: 3354644
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.
Ramel S; Reid BJ; Sanchez CA; Blount PL; Levine DS; Neshat K; Haggitt RC; Dean PJ; Thor K; Rabinovitch PS
Gastroenterology; 1992 Apr; 102(4 Pt 1):1220-8. PubMed ID: 1551529
[TBL] [Abstract][Full Text] [Related]
9. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study.
Canto MI; Setrakian S; Willis JE; Chak A; Petras RE; Sivak MV
Endoscopy; 2001 May; 33(5):391-400. PubMed ID: 11396755
[TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus and esophageal adenocarcinoma.
Reid BJ
Gastroenterol Clin North Am; 1991 Dec; 20(4):817-34. PubMed ID: 1787015
[TBL] [Abstract][Full Text] [Related]
11. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
13. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
[TBL] [Abstract][Full Text] [Related]
14. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
Jankowski J; Hopwood D; Pringle R; Wormsley KG
Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
[TBL] [Abstract][Full Text] [Related]
16. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.
Reid BJ; Levine DS; Longton G; Blount PL; Rabinovitch PS
Am J Gastroenterol; 2000 Jul; 95(7):1669-76. PubMed ID: 10925966
[TBL] [Abstract][Full Text] [Related]
17. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients.
Lee RG
Am J Surg Pathol; 1985 Dec; 9(12):845-52. PubMed ID: 2416226
[TBL] [Abstract][Full Text] [Related]
18. Progression to cancer in Barrett's esophagus is associated with genomic instability.
Rabinovitch PS; Reid BJ; Haggitt RC; Norwood TH; Rubin CE
Lab Invest; 1989 Jan; 60(1):65-71. PubMed ID: 2911184
[TBL] [Abstract][Full Text] [Related]
19. [Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases].
Robaszkiewicz M; Hardy E; Volant A; Nousbaum JB; Cauvin JM; Calament G; Robert FX; Saleun JP; Gouerou H
Gastroenterol Clin Biol; 1991; 15(10):703-10. PubMed ID: 1816011
[TBL] [Abstract][Full Text] [Related]
20. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]